Elevance Health
1,420 hedge funds and large institutions have $106B invested in Elevance Health in 2022 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 524 increasing their positions, 487 reducing their positions, and 93 closing their positions.
62% more first-time investments, than exits
New positions opened: 151 | Existing positions closed: 93
29% more funds holding in top 10
Funds holding in top 10: 52 → 67 (+15)
6% more capital invested
Capital invested by funds: $99.7B → $106B (+$6.03B)
3% more funds holding
Funds holding: 1,372 → 1,420 (+48)
8% more repeat investments, than reductions
Existing positions increased: 524 | Existing positions reduced: 487
0.64% more ownership
Funds ownership: 88.63% → 89.28% (+0.64%)
7% less call options, than puts
Call options by funds: $433M | Put options by funds: $466M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$850M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$593M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$309M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$290M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$203M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$479M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$312M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$226M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$197M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$187M |
ELV Hedge Fund Activity: Q1 2022 in Review
1,420 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q1 2022, worth a combined $106B — up 6% from $99.7B a quarter earlier.
Buyers outnumbered sellers: 151 funds opened new ELV positions and 93 closed out — a net gain of 58 holders — while 524 added to existing stakes and 487 trimmed.
The largest buyer was Vanguard Group, adding an estimated $850M. The largest seller was T. Rowe Price Associates, cutting an estimated $479M.
- 1,420 institutional investors held Elevance Health (ELV) as of Q1 2022, up from 1,372 in Q4 2021.
- Funds reported $106B of Elevance Health stock for Q1 2022, up 6% quarter-over-quarter.
- 151 funds opened new Elevance Health positions in Q1 2022 and 93 closed out, a net change of +58 holders.
- The largest Elevance Health buyer in Q1 2022 was Vanguard Group, an estimated $850M added.
- The largest Elevance Health seller in Q1 2022 was T. Rowe Price Associates, an estimated $479M sold.
Based on aggregated 13F filings for Q1 2022.